LARP7
La-related protein 7
Also known as: DKFZP564K112, HDCMA18P, LARP7_HUMAN, PIP7S
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4G0J3
- Gene
- LARP7
- Ensembl
- ENSG00000174720
- Chromosome
- 4
- Canonical length
- 582 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a protein which is found in the 7SK snRNP (small nuclear ribonucleoprotein). This snRNP complex inhibits a cyclin-dependent kinase, positive transcription elongation factor b, which is required for paused RNA polymerase II at a promoter to begin transcription elongation. A pseudogene of this gene is located on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
Canonical amino-acid sequenceUniProt
582 residues, UniProt reviewed canonical sequence.
>Q4G0J3|LARP7
1 METESGNQEK VMEEESTEKK KEVEKKKRSR VKQVLADIAK QVDFWFGDAN LHKDRFLREQ
61 IEKSRDGYVD ISLLVSFNKM KKLTTDGKLI ARALRSSAVV ELDLEGTRIR RKKPLGERPK
121 DEDERTVYVE LLPKNVNHSW IERVFGKCGN VVYISIPHYK STGDPKGFAF VEFETKEQAA
181 KAIEFLNNPP EEAPRKPGIF PKTVKNKPIP ALRVVEEKKK KKKKKGRMKK EDNIQAKEEN
241 MDTSNTSISK MKRSRPTSEG SDIESTEPQK QCSKKKKKRD RVEASSLPEV RTGKRKRSSS
301 EDAESLAPRS KVKKIIQKDI IKEASEASKE NRDIEISTEE EKDTGDLKDS SLLKTKRKHK
361 KKHKERHKMG EEVIPLRVLS KSEWMDLKKE YLALQKASMA SLKKTISQIK SESEMETDSG
421 VPQNTGMKNE KTANREECRT QEKVNATGPQ FVSGVIVKII STEPLPGRKQ VRDTLAAISE
481 VLYVDLLEGD TECHARFKTP EDAQAVINAY TEINKKHCWK LEILSGDHEQ RYWQKILVDR
541 QAKLNQPREK KRGTEKLITK AEKIRLAKTQ QASKHIRFSE YDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LARP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 47 nTPM
- tongue: 34 nTPM
- liver: 33 nTPM
- thymus: 31 nTPM
- kidney: 31 nTPM
- lymph node: 31 nTPM
Single-cell type
- hepatocytes: 181 nCPM
- oocytes: 175 nCPM
- syncytiotrophoblasts: 136 nCPM
- hepatic stellate cells: 136 nCPM
- kupffer cells: 124 nCPM
- esophageal basal cells: 114 nCPM
Immune cell
- basophil: 22 nTPM
- non-classical monocyte: 18 nTPM
- NK-cell: 16 nTPM
- intermediate monocyte: 14 nTPM
- memory B-cell: 14 nTPM
- eosinophil: 13 nTPM
Brain region
- hypothalamus: 25 nTPM
- midbrain: 18 nTPM
- medulla oblongata: 17 nTPM
- spinal cord: 15 nTPM
- thalamus: 15 nTPM
- pons: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LARP7.
Disease | AllUniProt
Conditions LARP7 is implicated in, by any mechanism.
- Alazami syndrome (ALAZS) MIM:615071
Disease | GeneticClinVar
84 pathogenic / likely-pathogenic of 380 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephalic primordial dwarfism, Alazami type
- Intellectual disability
- LARP7-related disorder
- Abnormal brain morphology
- Epileptic encephalopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- box C/D sno(s)RNA 3'-end processing
- cell differentiation
- mRNA processing
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription elongation by RNA polymerase II
- negative regulation of viral transcription
- positive regulation of protein localization to Cajal body
- positive regulation of snRNA transcription by RNA polymerase II
- regulation of mRNA splicing, via spliceosome
- RNA splicing
- spermatogenesis
- U6 2'-O-snRNA methylation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Lupus La protein
- La-type HTH domain
- Nucleotide-binding alpha-beta plait domain superfamily
- La protein, xRRM domain
- RNA-binding domain superfamily
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- La domain containing protein
- RNA recognition motif
- La domain
- RNA binding motif
- LARP7, RNA recognition motif 1
- LARP7, RNA recognition motif 2
- La-related protein 7, La domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LARP7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LARP7 as an antibody target. Whether an autoantibody or antibody against LARP7 could matter depends on whether native LARP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LARP7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LARP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...